Carregant...
A RARE CAUSE OF PITUITARY APOPLEXY: CABERGOLINE THERAPY
Pituitary apoplexy (PA) is a life-threatening clinical syndrome. Dopamine receptor agonists are the drugs of choice in the treatment of prolactinomas. The use of cabergoline is reported to cause an increased risk of PA, particularly in macroprolactinomas of cystic nature. In this report, we present...
Guardat en:
| Publicat a: | Acta Endocrinol (Buchar) |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Acta Endocrinologica Foundation
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6516607/ https://ncbi.nlm.nih.gov/pubmed/31149244 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4183/aeb.2018.113 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|